Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drug Safety
Published in: Drug Safety 6/2009

01-06-2009 | Editorial

Understanding and Communicating Key Concepts in Risk Management

What do we Mean by Benefit and Risk?

Authors: Professor I. Ralph Edwards, Marie Lindquist

Published in: Drug Safety | Issue 6/2009

Login to get access

Excerpt

Words can be used to express ideas and knowledge in ways that are not intended nor understood in the same way by the recipient. Following previous papers on definitions by Lindquist[1] and Hauben and Aronson,[2] in this editorial we explore some key concepts in risk management. We try to link the concepts with current trends, and try to find words that will support such concepts without moving far from their generally understood meanings. …
Literature
1.
2.
Hauben M, Aronson J. Defining ‘signal’ and its subtypes in pharmacovigilance based on a systematic review of previous definitions. Drug Safety 2009; 32(2): 99–110PubMedCrossRef
3.
Bombardier C, Maetzel A. Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies? Ann Rheum Dis 1999; 58 Suppl. 1: I82–5PubMedCrossRef
4.
Grimmer-Somers K, Vipond N, Kumar S, et al. A review and critique of assessment instruments for patients with persistent pain. J Pain Res 2009; 2: 21–47PubMedCrossRef
5.
Ware J. Methodological considerations in selection of health status assessment procedures. In: Wenger N, Mattson ME, Furberg CD, et al., editors. Assessment of quality of life in clinical trials of cardiovascular therapy. New York: LeJacq Publishing, 1984: 87–111
6.
7.
Edwards P. Homeopathy: patient-centred paradox, in anthropology. Dunedin: Otago University, 1986
Metadata
Title
Understanding and Communicating Key Concepts in Risk Management
What do we Mean by Benefit and Risk?
Authors
Professor I. Ralph Edwards
Marie Lindquist
Publication date
01-06-2009
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 6/2009
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200932060-00001

Other articles of this Issue 6/2009

Drug Safety 6/2009 Go to the issue

Short Communication

Safety and Drug Utilization Profile of Varenicline as Used in General Practice in England

Original Research Article

Topical Corticosteroids and the Risk of Diabetes Mellitus

Review Article

Behavioural Adverse Effects of Dopaminergic Treatments in Parkinson’s Disease

Leading Article

Potential Risks Associated with the Use of Herbal Anti-Obesity Products

Review Article

NSAIDs and the Risk of Accidental Falls in the Elderly

Review Article

Treatment of Chronic Non-Malignant Pain in the Elderly